Physician profile
Adithya Suresh
NPI 1376744979
$38,375.22
in general payments reported to CMS, 2019-2025
32 companies · $991 in 2025
The $991 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,009 · 2020: $374 · 2021: $7,639 · 2022: $12K · 2023: $7,855 · 2024: $7,370 · 2025: $991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,281 · Food and Beverage: $4,822 · Travel and Lodging: $4,112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,281.25 |
| Food and Beverage | $4,822.21 |
| Travel and Lodging | $4,112.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $30,235.57 | 2019-2025 | General - Therapies, Ranger, Eluvia |
| Lemaitre Vascular, INC. | $2,733.49 | 2023-2025 | Hydro Lemaitre Valvulotome, Restoreflow, Artegraft Vascular Graft |
| W. L. Gore & Associates, INC. | $1,351.65 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Medtronic, INC. | $999.76 | 2021-2025 | Abre, Endurant Iis, Hawkone |
| Philips North America LLC | $664.36 | 2019-2025 | (Az7) Lasers, (Br5) Peripheral Ivus, Labosys |
| Endologix LLC | $527.50 | 2019-2025 | Torus Stent Graft System, Endocross Device |
| Imperative Care, INC | $201.03 | 2024 | Prodigy Catheter, Symphony Catheter |
| Angiodynamics, INC. | $189.83 | 2021-2024 | Auryon Laser System 100-120 Vac |
| Inari Medical, INC. | $173.33 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Organogenesis INC. | $166.78 | 2021-2024 | Puraply |
| Biocompatibles, INC. | $150.75 | 2019 | |
| Integra Lifesciences Corporation | $139.20 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Alnylam Pharmaceuticals INC. | $124.95 | 2022 | |
| Silk Road Medical, INC. | $98.62 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Penumbra, INC. | $97.82 | 2022-2025 | Indigo System, Penumbra System |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $57.03 | 2024 | |
| Cardiovascular Systems INC. | $56.22 | 2022 | |
| Smith+Nephew, INC. | $45.34 | 2021-2025 | Pico |
| Convatec INC. | $44.77 | 2024 | |
| Cook Medical LLC | $35.73 | 2022 | |
| Veryan Medical Incorporated | $34.79 | 2021 | |
| Mozarc Medical US LLC | $31.77 | 2023 | Chameleon |
| Cardiva Medical, INC. | $31.13 | 2022 | |
| Neuros Medical, INC. | $30.67 | 2025 | Altius |
| Stryker Corporation | $27.61 | 2025 | Artix Mt |
| Becton, Dickinson and Company | $25.25 | 2024 | Rotarexs 6 F X 135 Cm |
| Tactile Systems Technology INC | $21.15 | 2025 | Flexitouch Plus, Nimbl |
| Cashflow Solutions, LLC | $20.62 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Bolton Medical INC | $18.39 | 2022 | |
| Medtronic Vascular, INC. | $13.55 | 2020 | |
| Bard Peripheral Vascular, INC. | $13.40 | 2020 | |
| Janssen Pharmaceuticals, INC | $13.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adithya Suresh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.